INSCX
Price
$20.70
Change
+$0.26 (+1.27%)
Updated
Jan 30 closing price
Net Assets
16.63M
RGAHX
Price
$77.55
Change
+$0.69 (+0.90%)
Updated
Jan 30 closing price
Net Assets
309.75B
Ad is loading...

INSCX vs RGAHX

Header iconINSCX vs RGAHX Comparison
Open Charts INSCX vs RGAHXBanner chart's image
Catalyst Insider Buying C
Price$20.70
Change+$0.26 (+1.27%)
VolumeN/A
Net Assets16.63M
American Funds Growth Fund of Amer R5E
Price$77.55
Change+$0.69 (+0.90%)
VolumeN/A
Net Assets309.75B
INSCX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
INSCX vs. RGAHX commentary
Feb 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSCX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 310B vs. INSCX (16.6M). RGAHX pays higher dividends than INSCX: RGAHX (0.64) vs INSCX (0.00). INSCX was incepted earlier than RGAHX: INSCX (14 years) vs RGAHX (9 years). INSCX is a more actively managed with annual turnover of: 214.00 vs. RGAHX (31.00). RGAHX has a lower initial minimum investment than INSCX: RGAHX (250) vs INSCX (2500). INSCX annual gain was more profitable for investors over the last year : 25.40 vs. RGAHX (22.85). RGAHX return over 5 years is better than : 54.13 vs. INSCX (-0.87).
INSCXRGAHXINSCX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years9 years-
Gain YTD4.0205.59672%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets16.6M310B0%
Annual Yield % from dividends0.000.64-
Returns for 1 year25.4022.85111%
Returns for 3 years22.1018.71118%
Returns for 5 years-0.8754.13-2%
Returns for 10 years35.10N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLIFX35.580.43
+1.22%
Value Line Mid Cap Focused
JGAQX38.100.21
+0.55%
JPMorgan Value Advantage R2
ARIOX11.24N/A
N/A
Aristotle/Saul Global Eq I
TAVFX58.99N/A
N/A
Third Avenue Value Instl
SIMYX10.97N/A
N/A
SEI Tax-Managed Intl Mgd Vol Y (SIMT)